MGI Pharma MOGN New patents, anti cancer Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MGI Pharma MOGN New patents, anti cancer

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: David Cathcart who wrote (1145)	12/8/1998 6:12:00 PM
From: Biomaven	of 1826

Seems like this trial is at standard NCI pace: PROJECTED ACCRUAL: This study will accrue up to 74 patients (37/stratum) in over 3 years. and ... Patients are followed every 4 weeks until death. That's the NCI for you - maybe they know how good MGI-114 is and the bureaucrats just want the trial to last for 20 years. <G> Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next